GOLDILOX-TIMI 69 is a Phase IIB, Randomized, Double-Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of MEDI6570 (a fully human monoclonal antibody against LOX-1) in Participants with a Prior Myocardial Infarction, Persistent Inflammation, and Elevated N-Terminal Prohormone Brain Natriuretic Peptide.

today V. 2 GOLDILOX-TIMI-69 (002) AZ

Contact Us about GOLDILOX

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close